SCHEMBL4657109

SCHEMBL4657109

CCCC[Sn](CCCC)(CCCC)c1cc(C)nn1C.Cc1ccn(C)n1

nearest known ligand 0.35

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 1/20 0.35
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2389874 0.88 KMT2A (0.36) MEN1KMT2A
SCHEMBL22657151 0.71 KDM4E (0.31)
SCHEMBL22445230 0.71
SCHEMBL28706249 0.71
SCHEMBL28704522 0.71 TLR8 (0.34) KMT2A
SCHEMBL1085974 0.71 CYP19A1 (0.42) CYP19A1KMT2A
SCHEMBL28218621 0.69 CYP19A1 (0.45) CYP19A1KMT2A
SCHEMBL22445382 0.69 DNM2 (0.31)
SCHEMBL6078557 0.69 MAPK1 (0.47)
SCHEMBL22445475 0.68

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1871749-A1 1H-QUINAZ0LINE-2,4-DIONES AND THEIR USE AS AMPA-RECEPTOR LIGANDS Novartis AG (US) 2008-01-02 EP disclosed
WO-2006108591-A1 1H-QUINAZ0LINE-2,4-DIONES AND THEIR USE AS AMPA-RECEPTOR LIGANDS NOVARTIS AG (CH) 2006-10-19 WO disclosed